Genetic determinants of mitochondrial response to arsenic in yeast Saccharomyces cerevisiae

Cancer Research

Volumn 67, Issue 20, 2007, Pages 9740-9749

  Vujcic, Marija ^a   Shroff, Meghna ^a   Singh, Keshav K ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENATE SODIUM;

ACIDIFICATION; ARTICLE; BIOGENESIS; COMPUTER PROGRAM; CONTROLLED STUDY; GENE TARGETING; HEREDITY; MITOCHONDRION; NONHUMAN; NUCLEIC ACID METABOLISM; OXIDATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; SACCHAROMYCES CEREVISIAE; SCREENING; SENSITIVITY ANALYSIS; YEAST;

ARSENATES; ARSENIC; ARSENITES; DNA, MITOCHONDRIAL; DNA-BINDING PROTEINS; GENE DELETION; HUMANS; MITOCHONDRIA; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; TRANSCRIPTION FACTORS;

EID: 35449003603     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-1962     Document Type: Article

References (53)

1. De Chaudhuri SMJ, Das JK, Mukherjee A, et al. Association of specific p53 polymorphisms with keratosis in individuals exposed to arsenic through drinking water in west Bengal, India. Mutation Research 2006; 601:102-12.
2. Banerjee MSJ, Das JK, Mukherjee A, Sarkar AK, Mondal L, Giri AK. Polymorphism in the ERCC2 codon 751 is associated with arsenic-induced premalignant hyperkeratosis and significant chromosome aberrations. Carcinogenesis 2007;28:672-6.
3. Bhattarcharjee Y. A sluggish response to humanity's biggest mass poisoning. Science 2007;315:1659-61.
4. Waalkes MP, Fox DA, States JC, Patierno SR, McCabe MJ, Jr. Metals and disorders of cell accumulation: modulation of apoptosis and cell proliferation. Toxicol Sci 2000;56:255-61.
5. Tchounwou PB, Patlolla AK, Centeno JA. Carcinogenic and systemic health effects associated with arsenic exposure - a critical review. Toxicol Pathol 2003;31:575-88.
6. Chappell WR, Beck BD, Brown KG, et al. Inorganic arsenic: a need and an opportunity to improve risk assessment. Environ Health Perspect 1997;105:1060-7.
7. Soignet SL, Frankel SR, Douer D, et al. United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. J Clin Oncol 2001;19:3852-60.
8. Soignet SL, Maslak P, Wang ZG, et al. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med 1998;339: 1341-8.
9. Miller WH, Jr., Schipper HM, Lee JS, Singer J, Waxman S. Mechanisms of action of arsenic trioxide. Cancer Res 2002;62:3893-903.
10. Corsini E, Asti L, Viviani B, Marinovich M, Galli CL. Sodium arsenate induces overproduction of interleukin-1α in murine keratinocytes: role of mitochondria. J Invest Dermatol 1999;113:760-5.
11. Wohlrab H. Molecular aspects of inorganic phosphate transport in mitochondria. Biochim Biophys Acta 1986;853:115-34.
12. Indiveri C, Capobianco L, Kramer R, Palmieri F. Kinetics of the reconstituted dicarboxylate carrier from rat liver mitochondria. Biochim Biophys Acta 1989;977: 187-93.
13. Vahter M, Marafante E. Intracellular distribution and chemical forms of arsenic in rabbits exposed to arsenate. Biol Trace Elem Res 1989;21:233-9.
14. Crane RK, Lipmann F. The effect of arsenate on aerobic phosphorylation. J Biol Chem 1953;201:235-43.
15. Tugendreich S, Bassett DE, Jr., McKusick VA, Boguski MS, Hieter P. Genes conserved in yeast and humans. Hum Mol Genet 1994;3 Spec No:1509-17.
16. Goffeau A, Barrell BG, Bussey H, et al. Life with 6000 genes. Science 1996;274:546, 563-7.
17. Johnston M. The yeast genome: on the road to the Golden Age. Curr Opin Genet Dev 2000;10:617-23.
18. Winzeler EA, Shoemaker DD, Astromoff A, et al. Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 1999;285: 901-6.
19. Foury F. Human genetic diseases: a cross-talk between man and yeast. Gene 1997;195:1-10.
20. Steinmetz LM, Scharfe C, Deutschbauer AM, et al. Systematic screen for human disease genes in yeast. Nat Genet 2002;31:400-4.
21. Giaever G, Chu AM, Ni L, et al. Functional profiling of the Saccharomyces cerevisiae genome. Nature 2002;418: 387-91.
22. Wysocki R, Bobrowicz P, Ulaszewski S. The Saccharomyces cerevisiae ACR3 gene encodes a putative membrane protein involved in arsenite transport. J Biol Chem 1997;272:30061-6.
23. Liu SX, Davidson MM, Tang X, et al. Mitochondrial damage mediates genotoxicity of arsenic in mammalian cells. Cancer Res 2005;65:3236-42.
24. Nemeti B, Gregus Z. Mitochondria work as reactors in reducing arsenate to arsenite. Toxicol Appl Pharmacol 2002;182:208-18.
25. Ghosh M, Shen J, Rosen BP. Pathways of As(III) detoxification in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A 1999;96:5001-6.
26. Epstein CB, Waddle JA, Hale Wt, et al. Genome-wide responses to mitochondrial dysfunction. Mol Biol Cell 2001;12:297-308.
27. Liu Y, Pu Y, Zhang X. Role of the mitochondrial signaling pathway in murine coronavirus-induced oligodendrocyte apoptosis. J Virol 2006;80:395-403.
28. Rosen BP. Biochemistry of arsenic detoxification. FEBS Lett 2002;529:86-92.
29. Yoshinaga SK, Peterson CL, Herskowitz I, Yamamoto KR. Roles of SWI1, SWI2, and SWI3 proteins for transcriptional enhancement by steroid receptors. Science 1992;258:1598-604.
30. Burns LG, Peterson CL. The yeast SWI-SNF complex facilitates binding of a transcriptional activator to nucleosomal sites in vivo. Mol Cell Biol 1997;17:4811-9.
31. Laurent BC, Treitel MA, Carlson M. Functional interdependence of the yeast SNF2, SNF5, and SNF6 proteins in transcriptional activation. Proc Natl Acad Sci U S A 1991;88:2687-91.
32. Sidorova JM, Mikesell GE, Breeden LL. Cell cycle-regulated phosphorylation of Swi6 controls its nuclear localization. Mol Biol Cell 1995;6:1641-58.
33. Hengartner CJ, Thompson CM, Zhang J, et al. Association of an activator with an RNA polymerase II holoenzyme. Genes Dev 1995;9:897-910.
34. Hardie DG, Carling D, Carlson M. The AMP-activated/ SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu Rev Biochem 1998;67:821-55.
35. Aon MA, Cortassa S. Catabolite repression mutants of Saccharomyces cerevisiae show altered fermentative metabolism as well as cell cycle behavior in glucose-limited chemostat cultures. Biotechnol Bioeng 1998;59: 203-13.
36. Hei TK, Filipic M. Role of oxidative damage in the genotoxicity of arsenic. Free Radic Biol Med 2004;37: 574-81.
37. van Loon AP, Pesold-Hurt B, Schatz G. A yeast mutant lacking mitochondrial manganese-superoxide dismutase is hypersensitive to oxygen. Proc Natl Acad Sci U S A 1986;83:3820-4.
38. Rodriguez-Manzaneque MT, Ros J, Cabiscol E, Sorribas A, Herrero E. Grx5 glutaredoxin plays a central role in protection against protein oxidative damage in Saccharomyces cerevisiae. Mol Cell Biol 1999;19:8180-90.
39. Lodish HBA, Zipursky SL, Matsudaira P, Baltimore D, Darnell JE. Molecular cell biology. 4th ed. New York: W.H. Freeman and Company; 2000.
40. 2+ homeostasis of yeast cells. J Biol Chem 1995;270:10113-9.
41. Luk E, Carroll M, Baker M, Culotta VC. Manganese activation of superoxide dismutase 2 in Saccharomyces cerevisiae requires MTM1, a member of the mitochondrial carrier family. Proc Natl Acad Sci U S A 2003;100: 10353-7.
42. Moffat JHD, Andrews B. Functions of Pho85 cyclin-dependent kinases in budding yeast. Prog Cell Cycle Res 2000;4:97-106.
43. Wheeler RT, Kupiec M, Magnelli P, Abeijon C, Fink GR. A Saccharomyces cerevisiae mutant with increased virulence. Proc Natl Acad Sci U S A 2003;100:2766-70.
44. Wang PJ, Chabes A, Casagrande R, Tian XC, Thelander L, Huffaker TC. Rnr4p, a novel ribonucleotide reductase small-subunit protein. Mol Cell Biol 1997;17:6114-21.
45. Peterson CL, Tamkun JW. The SWI-SNF complex: a chromatin remodeling machine? Trends Biochem Sci 1995;20:143-6.
46. Jiang F, Ryan MT, Schlame M, et al. Absence of cardiolipin in the crd1 null mutant results in decreased mitochondrial membrane potential and reduced mitochondrial function. J Biol Chem 2000;275:22387-94.
47. Timblin BK, Tatchell K, Bergman LW. Deletion of the gene encoding the cyclin-dependent protein kinase Pho85 alters glycogen metabolism in Saccharomyces cerevisiae. Genetics 1996;143:57-66.
48. Loo S, Laurenson P, Foss M, Dillin A, Rine J. Roles of ABF1, NPL3, and YCL54 in silencing in Saccharomyces cerevisiae. Genetics 1995;141:889-902.
49. Morrow BE, Johnson SP, Warner JR. Proteins that bind to the yeast rDNA enhancer. J Biol Chem 1989;264: 9061-8.
50. Yang-Feng TL, Barton DE, Thelander L, Lewis WH, Srinivasan PR, Francke U. Ribonucleotide reductase M2 subunit sequences mapped to four different chromosomal sites in humans and mice: functional locus identified by its amplification in hydroxyurea-resistant cell lines. Genomics 1987;1:77-86.
51. Xue L, Zhou B, Liu X, Qiu W, Jin Z, Yen Y. Wild-type p53 regulates human ribonucleotide reductase by protein-protein interaction with p53R2 as well as hRRM2 subunits. Cancer Res 2003;63:980-6.
52. Lee TB, Lim DY, Jeon HJ, et al. Differential induction of Mn-containing superoxide dismutase by paraquat in peripheral lymphocytes of normal subjects and gastric cancer patients. Mol Cells 2003;16:13-8.
53. Russo D, Bisca A, Celano M, et al. Proteomic analysis of human thyroid cell lines reveals reduced nuclear localization of Mn-SOD in poorly differentiated thyroid cancer cells. J Endocrinol Invest 2005;28:137-44.